AVASTIN (bevacizumab) Patient Assistance Program
Don’t let the high cost of brand specialty oncology biologics stand between you and the treatment you need. We help eligible patients access Avastin (bevacizumab) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Avastin (bevacizumab) is FDA-approved across multiple cancers — metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent/recurrent/metastatic cervical cancer, ovarian cancer (epithelial, fallopian tube, primary peritoneal), and hepatocellular carcinoma — typically in combination with chemotherapy.
- Without assistance, Avastin costs commonly run $5,000–$10,000+ per IV infusion at the standard 5–15 mg/kg dose, with monthly totals depending on regimen and body weight. Annual costs commonly reach $80,000+.
- Through AffordMyPrescriptions, qualifying patients can access Avastin coverage for a flat $69.95 per month — our advocacy team manages the entire enrollment, infusions, and renewal process.
- Multiple FDA-approved biosimilars to Avastin (Mvasi, Zirabev, Alymsys, Vegzelma, Avzivi) are now available at significantly lower cost — substitution depends on your oncology team and infusion site.
What Is Avastin Prescription Assistance Program?
The Avastin Prescription Assistance Program is a manufacturer-sponsored initiative that provides Avastin infusions at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for cancer patients who are uninsured or underinsured, as well as Medicare beneficiaries.
Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, prior-authorization documentation, infusion scheduling, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing infusion-schedule coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, Avastin infusions cost roughly $5,000–$10,000+ each. Multiple biosimilars are available at lower cost. A Patient Assistance Program is the meaningful path for brand pricing — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Per IV infusion (brand) | ~$8,000.00 | Save ~$7,930/dose |
| Per IV infusion (biosimilar) | ~$4,500.00 | Save ~$4,430/dose |
| Monthly cost (typical) | ~$8,000+ | Save ~$7,930/mo |
| Annual treatment cost | ~$96,000+ | Save ~$95,000+/yr |
| Combo with chemo (cycle) | Add’l cost | Coordinated by us |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Avastin Prescription Program?
The Patient Assistance Program is free to apply for and provides Avastin infusions at little or no medication cost if approved. But the process involves detailed applications, oncology-team coordination, prior-authorization documentation, infusion scheduling, and ongoing renewal management. Our $69.95/month service covers full advocacy. With multiple Avastin biosimilars available at significantly lower cost, we’ll guide you to the most cost-effective path.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Avastin:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
- Still $5,000–$10,000+ per infusion per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Avastin assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Avastin Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Avastin:
Avastin (bevacizumab) is an intravenous (IV) anti-VEGF monoclonal antibody used to treat several advanced cancers, typically in combination with chemotherapy. It works by blocking the tumor blood-supply system rather than directly killing cancer cells. It is given as an IV infusion every 2–3 weeks depending on the regimen.
How Avastin Works:
Cancers often grow by recruiting new blood vessels through a protein signal called VEGF, which provides the tumor with essential oxygen and nutrients. Avastin is a monoclonal antibody that binds to VEGF, blocking it from connecting to receptors and effectively “starving” the tumor of its blood supply. This process inhibits new vessel formation and causes existing tumor vessels to regress, which can also help chemotherapy work more effectively.
Form and use:
Avastin is administered as an intravenous (IV) infusion within a hospital, clinic, or specialized infusion center. The specific dosage is determined by the patient’s weight and the particular type of cancer being treated, typically ranging from 5 to 15 mg/kg every 2 to 3 weeks. An oncology team manages the schedule based on the patient’s specific treatment regimen and any accompanying chemotherapy partners.
Generic availability:
While there is no traditional generic, several FDA-approved biosimilars for Avastin (bevacizumab) are available, such as Mvasi, Zirabev, and Alymsys. These biosimilars generally offer a lower-cost alternative to the brand-name medication. The choice between Avastin or a biosimilar depends on the prescribing oncologist, the infusion site’s contracts, and the patient’s insurance coverage.
Warnings:
Avastin includes serious boxed warnings regarding gastrointestinal perforations, severe hemorrhage, and complications with surgery or wound healing. Patients are also monitored for hypertension, kidney issues like proteinuria, and cardiovascular events such as congestive heart failure or arterial clots. Your oncology team will regularly check blood pressure and urine protein levels to manage these potential risks throughout treatment.
FAQ (Frequently Asked Questions)
How Much Does Avastin Cost Without Insurance?
Per-infusion costs commonly run $5,000–$10,000+ for brand Avastin at the standard dose. Biosimilars are typically 30–40% cheaper. Annual treatment costs commonly reach $80,000+. Through AffordMyPrescriptions, qualifying patients receive Avastin (or biosimilar) at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Are Biosimilars To Avastin The Same Medicine?
Biosimilars (Mvasi, Zirabev, Alymsys, Vegzelma, Avzivi) are FDA-approved as highly similar to and clinically equivalent to brand Avastin (bevacizumab). They contain the same active ingredient and produce the same clinical results. Whether your infusion is filled as brand Avastin or a biosimilar depends on your oncology team and infusion site — but for many patients, the biosimilar at lower cost is the right path.
How Is Avastin Given?
Avastin is given as an IV infusion in a clinic, infusion center, or hospital outpatient setting. The dose is weight-based and depends on the indication (typically 5–15 mg/kg every 2–3 weeks). The first infusion is given over 90 minutes; subsequent infusions are usually given over 30–60 minutes if the first is well-tolerated.
What Side Effects Should I Watch For?
Important side effects include high blood pressure, protein in the urine (your team will monitor with regular tests), bleeding (sometimes serious), wound-healing problems (Avastin is usually held before surgery), gastrointestinal perforations (rare but serious), and arterial blood clots. Tell your oncology team promptly about new headaches, severe abdominal pain, blood in stool, sudden vision changes, or unusual bleeding.
Can I Get Avastin Through The PAP If I Have Medicare?
Yes. Medicare beneficiaries can typically qualify for Avastin Patient Assistance, especially if you face significant out-of-pocket costs under medical or pharmacy benefits. The manufacturer’s commercial copay assistance program is reserved for commercially insured patients only.
What If My Application Is Denied?
If your initial application is denied, we explore alternatives — switching to an Avastin biosimilar at significantly lower cost, the manufacturer’s copay assistance program if you have commercial insurance, independent oncology foundations such as the PAN Foundation or HealthWell Foundation, or asking your oncology team whether a different anti-angiogenic therapy would be appropriate. If we cannot find a path, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Avastin, our team may be able to help you access assistance programs — or guide you to the cheaper biosimilar path if it is the better fit. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.